Richard Pazdur, MD, director of the U.S. Food and Drug Administration’s Oncology Center of Excellence (OCE), joins Lisa Kennedy Sheldon, PhD, APRN, AOCNP®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss oncology nurses’ contributions to cancer care, OCE’s initiatives, and the COVID-19 coronavirus pandemic’s implications for oncology drug approvals.   Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0    Episode Notes  Check out these resources from today’s episode:  FDA new drug approval announcements on ONS Voice Richard Pazdur’s biography Oncology Center of Excellence FDA Guidance on Conduct of Clinical Trials During COVID-19 FDA Community Outreach and Education Programs Project Facilitate Project Orbis Register for the Mosaic of Oncology Nursing webinar on May 19 from 2–3 pm EST. COVID-19 articleson ONS Voice  ONS Information Regarding the Coronavirus (COVID-19) ONS Interim PPE Guidelines During the COVID-19 Pandemic